Related Experiment Video
Updated: Jun 8, 2026

03:36
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
Can serologic markers help determine prognosis and guide therapy?
1Pediatric IBD Center, Department of Pediatrics, Cedars-Sinai Medical Center, David Geffen School of Medicine Los Angeles, CA, USA. dubinskym@cshs.org
Digestive Diseases (Basel, Switzerland)
|October 8, 2010
Abstract:
The search for biologic markers that can assess the natural history and perhaps predict the course of an individual's disease - including response to treatments over time - has become an important focus of inflammatory bowel disease research. The knowledge of an individual's prognosis can help physicians and patients make important management decisions and aid communication on risks and benefits of disease and treatment.
